Digest Network Come funziona
Network
/
Società
TI
Non verificato

TIXiMED, Inc.

Di cosa scriviamo

FarmaceuticaIndustriaMedicina - VarieSaluteSanità

6 comunicati stampa

Guarda tutti i comunicati
30/07/2026
Mercato del lavoro
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
TIXiMED Appoints Stephen Daly and Albert R. Collinson, Ph.D., to Board of Directors
Fonte
TIXiMED, Inc.
Emittente
Business Wire
1.00
0
07/07/2026
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Industria
TIXiMED Initiates Phase 1b Multiple Ascending Dose Study of TIX100
Fonte
TIXiMED, Inc.
Emittente
Business Wire
1.00
0
13/03/2026
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
TIXiMED Announces Expansion of Program-Related Investment from the Helmsley Charitable Trust
Fonte
TIXiMED, Inc.
Emittente
Business Wire
1.00
0
10/03/2026
Industria
Scienza
Attrezzature medico-sanitarie
Salute
Fitness
Medicina - Varie
Farmaceutica
Sanità
TIXiMED Announces Promising Preclinical Data: Oral TIX100 Prevents Weight Regain After GLP-1 Cessation in Obesity Model
Fonte
TIXiMED, Inc.
Emittente
Business Wire
1.00
0
29/05/2025
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Industria
TIXiMED Announces Successful Completion of a Phase 1 Study of its Novel Oral Disease-Modifying Type 1 Diabetes Therapy
Fonte
TIXiMED, Inc.
Emittente
Business Wire
1.00
0
19/12/2024
Industria
Biotecnologia
Igiene alimentare
Salute
Associazioni/Professionisti
Sanità
Farmaceutica
Scienza
Medicina - Varie
TIXiMED Announces a $2.65M Program-Related Investment from the Helmsley Charitable Trust to Initiate Clinical Trials of Its Novel Oral Therapy for Beta Cell Survival and Function
Fonte
TIXiMED, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0